Doxazosin
- Product NDC
- 50090-5773
- 11-digit product format
- 500905773
- Labeler code
- 50090
- Product ID
- 50090-5773_6101bbe5-fd09-48bc-9b58-cd7d3df325b2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxazosin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA202824
- Marketing category
- ANDA
- Marketing start
- 2017-06-14
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Doxazosin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DOXAZOSIN MESYLATE | 2 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 86P6PQK0MU |
| Rxcui | 197626 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-5773-0 | Doxazosin | 30 in 1 BOTTLE | TABLET | 30 | | 9 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-5773 | DOXAZOSIN TABLET [A-S MEDICATION SOLUTIONS] | 9 | Current NDC, Legacy NDC, 1 package rows | 20240612_9f67fa58-f623-4145-9e2c-98feee7ca45f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-5773-0 | 50090577300 | 30 TABLET in 1 BOTTLE (50090-5773-0) | 30 tablet | 2021-10-07 | 0000-00-00 | No | No | Current |